In-Vitro Colorectal Cancer Screening Tests Market: Top 3 trends driving the industry demand through 2025

The demand for in-vitro colorectal cancer screening tests is projected to grow at a steady pace in the coming years majorly due to growing geriatric population that is susceptible to colorectal cancer.

The demand for in-vitro colorectal cancer screening tests is projected to grow at a steady pace in the coming years majorly due to growing geriatric population that is susceptible to colorectal cancer. Rising prevalence of chronic disorders like inflammatory bowel disease, obesity, and type 2 diabetes coupled with increasing adoption of sedentary lifestyle could propel the cases of colorectal cancer.

DNA testing and molecular screening plays a vital role in diagnosing cancer at an early stage. As a result, these tests are being preferred by numerous healthcare professionals. Surging practice of assessing susceptible individuals for inherited colorectal cancer could augment individual gene testing and subsequently the shift to whole exome or whole genome sequencing.

Additionally, factors like technological advancement in the field of cancer screening, rapid expansion of screening activities and enhancement of efficient patient management systems could broaden the business outlook for in-vitro colorectal cancer (CRC) screening test providers. According to Global Market Insights, Inc., the in-vitro colorectal cancer screening tests market could be worth USD 1.3 billion by the year 2025.

Mentioned below are some of the trends that will support this growth:

  1. Prominence of fecal occult blood tests -

Fecal occult blood tests (FOBT) come as a cost-effective diagnostic option. In 2018, the FOBT segment controlled almost 83.8% of the entire market revenue share. Furthermore, the segment is estimated to record a CAGR of 4.7% within 2025. Increasing sensitivity and specificity of stool-based tests could enhance the adoption of FOBTs in the future.

A fecal occult blood test is often considered as an early screening test for colorectal cancer. It is employed to analyze other conditions that lead to bleeding in the digestive tract. In fact, the National Cancer Institute advises people aged above 50 to regularly perform screenings for colorectal cancer.

  1. Robust growth opportunities across Europe and North America -

Rising presence of geriatric population supported by increasing susceptibility of the elderly to contract colorectal diseases could stimulate the demand for in-vitro colorectal cancer screening tests across North America. in-vitro colorectal cancer screening tests market is also gaining steady traction across Europe. Research suggests that the in-vitro colorectal cancer screening tests market in Europe could register a compound annual growth rate of 5% by the end of 2025.

To access sample pages of this report titled, “In-Vitro Colorectal Cancer Screening Tests Market Size by Test Type (Fecal Occult Blood Tests [Guaiac FOB Stool, Immuno-FOB Agglutination, Lateral Flow Immuno-FOB, Immuno-FOB ELISA], Biomarker Tests [Tumor M2-PK Stool, Transferrin Assays], CRC DNA Screening Tests [Methylated Gene Testing, Panel DNA Tests]), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025” in detail along with the table of contents, please click on the link below:

https://www.gminsights.com/request-sample/detail/451

  1. Adoption of lucrative business strategies -

The in-vitro colorectal cancer screening tests market players like Abbott Molecular, Siemens Healthcare, Qiagen, EMD Millipore, Beckman Coulter, Eiken Chemical, and Alere are concentrating on innovative research and development projects to create advanced tests that would be able to deliver precise results instantly.

Taking October 2020 for instance, in vitro diagnostics firm, Todos Medical revealed that it has bagged a notice of allowance from the European Patent Office for the TBIA (Total Biochemical Infrared Analysis) platform that focuses on identifying benign colon cancer in peripheral blood.

About Global Market Insights, Inc.

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Website: https://www.gminsights.com